Applied Therapeutics Inc (Applied Therapeutics) is a clinical-stage biopharmaceutical company that discovers and develops transformative drugs in areas of Galactosemia and Diabetic Cardiomyopathy (DbCM). The company product pipeline includes include AT-001 a novel aldose reductase inhibitor, AT-007 a SORD Deficiency, AT-001 a Diabetic Peripheral Neuropathy. Applied Therapeutics also develops preclinical pipeline product AT-003, an ARI designed for the treatment of diabetic retinopathy and AT-104 a PI3K inhibitor for treating orphan hematological oncology T Cell Acute Lymphoblastic Leukaemia. It serves customers throughout the US. Applied Therapeutics is headquartered in New York, the US.
Headquarters
United States of America
Address
545 Fifth Avenue, Suite 1400, New York, 10017
Website
www.appliedtherapeutics.com
Telephone
1 212 2209226
No of Employees
25
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
APLT (NASD)
Revenue (2022)
$10.0M
EPS
XYZ
Net Income (2022)
XYZ
-45.2%
(2022 vs 2021)
Market Cap*
$501.9M
Net Profit Margin (2022)
XYZ
0.0%
(2022 vs 2021)
* As of and is in US$
Applied Therapeutics Inc premium industry data and analytics
Products and Services
| Products |
|---|
| Pipeline |
| AT-001 - Diabetic complications, Diabetic Peripheral Neuropathy |
| AT-007 - Rare Diseases |
| XYZ |
| XYZ |
| XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2024 | Others | In January, the company submitted a new drug application for govorestat to the U.S. Food and Drug Administration. |
| 2023 | Contracts/Agreements | In January, the company announced a partnership with Advanz Pharma for commercialization of AT-007 (govorestat) in Europe. |
| 2022 | Others | In June, the company announced designation of AT-007 (gavorestat) as an orphan medicinal product by the European Medicines Agency (EMA) for treatment of Galactosemia (Galactosaemia). |
Competitor Comparison
| Key Parameters | Applied Therapeutics Inc | Sage Therapeutics Inc | PhaseBio Pharmaceuticals Inc | BlueWillow Biologics Inc | Microbiotix Inc |
|---|---|---|---|---|---|
| Headquarters | United States of America | United States of America | United States of America | United States of America | United States of America |
| City | New York | Cambridge | Malvern | Ann Arbor | Worcester |
| State/Province | New York | Massachusetts | Pennsylvania | Michigan | Massachusetts |
| No. of Employees | 25 | 487 | 60 | - | - |
| Entity Type | Public | Public | Public | Private | Private |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Shoshana Shendelman | Chairman; Chief Executive Officer; President | Executive Board | 2016 | 43 |
| Riccardo Perfetti | Chief Medical Officer | Senior Management | 2018 | 62 |
| Dale Hooks | Chief Commercial Officer | Senior Management | 2024 | - |
| Les Funtleyder | Director | Non Executive Board | 2016 | 52 |
| Teena Lerner | Director | Non Executive Board | 2017 | 64 |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward